James Rothman

Prof. James Rothman is one of the world's most distinguished biochemists. He was awarded the Nobel Prize in Physiology or Medicine in 2013 for his work in the field of vesicle trafficking, which revolutionized our understanding of how cells are organized and how they form and secrete glycoproteins. He previously served as Vice Chairman of the Sloan-Kettering Institute for Cancer Research, as Chief Science Officer of GE Healthcare, and as senior advisor to R&D leadership at several biopharma companies, most recently GSK and Eli Lilly.